Technetium-99m pyrophosphate cardiac SPECT in endomyocardial biopsy negative cardiac amyloidosis
Cardiac amyloidosis is an under-appreciated cause of heart failure. Establishing a diagnosis is important because traditional heart failure treatment regimens can worsen left ventricular failure in this disease. Endomyocardial biopsy is the gold standard for diagnosis; however, scintigraphy with rad...
Main Authors: | Martin Krupa, MD, Rina Nguyen, BS, Jonathan Revels, DO, Lester S. Johnson, MD, PhD, FACR |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Radiology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1930043318302267 |
Similar Items
-
Consensus to 99mTechnetium-Pyrophosphate Scintigraphy in the Diagnosis of Transthyretin-related Cardiac Amyloidosis
by: REN Chao, et al.
Published: (2022-01-01) -
Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT
by: Chao Ren, et al.
Published: (2021-01-01) -
Iatrogenic intramuscular hematoma of the oblique muscles as a complication of technetium-99m-labeled pyrophosphate imaging-based computed tomography-guided core-needle biopsy in a patient with wild-type transthyretin cardiac amyloidosis
by: Koji Takahashi, MD, PhD, et al.
Published: (2024-01-01) -
Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with <sup>99m</sup> Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow
by: Mariam Saleem, et al.
Published: (2023-02-01) -
Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
by: Simona Ben-Haim, et al.
Published: (2021-09-01)